Novel cell directed glutaminase inhibitors as chemotherapeutic agents for hematological malignancies

被引：0
|
作者：
Zimmermann, Sarah [1 ]
Gadiano, Alexandra [1 ]
Alt, Jesse [1 ]
Tenora, Lukas [2 ]
Furtmueller, Georg [1 ]
Garrett, Caroline [1 ]
Majer, Pavel [2 ]
Rais, Rana [1 ]
Slusher, Barbara [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 254卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
318
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The promise of Janus kinase inhibitors in the treatment of hematological malignancies
    Senkevitch, Emilee
    Durum, Scott
    CYTOKINE, 2017, 98 : 33 - 41
  • [42] Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
    Hradska, Katarina
    Hajek, Roman
    Jelinek, Tomas
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] Histone deacetylase inhibitors: clinical implications for hematological malignancies
    Tambaro, Francesco Paolo
    Dell'Aversana, Carmela
    Carafa, Vincenzo
    Nebbioso, Angela
    Radic, Branka
    Ferrara, Felicetto
    Altucci, Lucia
    CLINICAL EPIGENETICS, 2010, 1 : 25 - 44
  • [44] mTOR kinase inhibitors as a treatment strategy in hematological malignancies
    Grzybowska-Izydorczyk, Olga
    Smolewski, Piotr
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (04) : 487 - 504
  • [45] Histone deacetylase inhibitors in hematological malignancies and solid tumors
    Chun, Pusoon
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (06) : 933 - 949
  • [46] Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
    Hou, Jing-Zhou
    Ye, Jing Christine
    Pu, Jeffrey J.
    Liu, Hongtao
    Ding, Wei
    Zheng, Hong
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [47] Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
    Jing-Zhou Hou
    Jing Christine Ye
    Jeffrey J. Pu
    Hongtao Liu
    Wei Ding
    Hong Zheng
    Delong Liu
    Journal of Hematology & Oncology, 14
  • [48] Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies
    Lin, Steven H.
    Kleinberg, Lawrence R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 343 - 359
  • [49] 2ND MALIGNANCIES ASSOCIATED WITH CHEMOTHERAPEUTIC-AGENTS
    KYLE, RA
    SEMINARS IN ONCOLOGY, 1982, 9 (01) : 131 - 142
  • [50] CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies
    Parlati, Francesco
    Demo, Susan D.
    Gross, Matthew I.
    Janes, Julie R.
    Lewis, Evan R.
    MacKinnon, Andy L.
    Rodriguez, Mirna L. M.
    Shwonek, Peter J.
    Wang, Taotao
    Yang, Jinfu
    Zhang, Dong
    Zhao, Frances
    Bennett, Mark K.
    CANCER RESEARCH, 2014, 74 (19)
12345